SMAD2 and T-cell non-Hodgkin lymphoma: The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes T-cell lymphoma progression and chemoresistance, as seen in T-cell lymphoblastic lymphoma [24].